| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/14/2013 | US20130039936 Immunogenic pote peptides and methods of use |
| 02/14/2013 | US20130039931 Antibodies Against A Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof |
| 02/14/2013 | US20130039927 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies |
| 02/14/2013 | US20130039918 Pharmaceutical Composition Using Connective-tissue Growth Factor |
| 02/14/2013 | US20130039916 ENGINEERED ANTI-IL-23p19 ANTIBODIES |
| 02/14/2013 | US20130039913 Heterodimeric antibody fc-containing proteins and methods for production thereof |
| 02/14/2013 | US20130039901 Treatment of Pompe's Disease |
| 02/14/2013 | US20130039894 Polypeptides and Use Thereof for Treatment of Traumatic or Degenerative Neuronal Injury |
| 02/14/2013 | US20130039889 Recombinant microorganisms |
| 02/14/2013 | US20130039888 Products and methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders |
| 02/14/2013 | US20130039850 Heterologous antibodies which bind human cd4 |
| 02/14/2013 | US20130037040 Compositions and methods for minimizing nornicotine synthesis in tobacco |
| 02/14/2013 | DE102011080853A1 Verfahren zur Isolierung von RNA aus Volblutproben A process for the isolation of RNA from Volblutproben |
| 02/14/2013 | CA2846211A1 Microrna biomarkers |
| 02/14/2013 | CA2844529A1 Method for producing isopropyl alcohol by continuous culture |
| 02/14/2013 | CA2844434A1 Plants with altered glucuronoxylan methyl transferase activity and methods of use |
| 02/14/2013 | CA2844402A1 Gem-difluorinated c-isopropylgalactoside derivates |
| 02/14/2013 | CA2844239A1 Methods for increasing co2 assimilation and oil production in photosynthetic organisms |
| 02/14/2013 | CA2844070A1 Humanized universal light chain mice |
| 02/14/2013 | CA2843960A1 Antibodies binding to phosphorylcholine (pc) and/or pc conjugates |
| 02/14/2013 | CA2843642A1 Use of dig3 insecticidal crystal protein in combination with cry1ab |
| 02/14/2013 | CA2843606A1 Recombinant production of steviol glycosides |
| 02/14/2013 | CA2843558A1 Novel peptides, compositions comprising the same and uses thereof in methods for the treatment of metabolic, cardiac and immune-related disorders |
| 02/14/2013 | CA2842726A1 Matrix and method for purifying and/or isolating nucleic acids |
| 02/14/2013 | CA2841831A1 Methods and compositions for production of vaccina virus |
| 02/14/2013 | CA2841181A1 Novel anti-human ngf antibody |
| 02/13/2013 | EP2557179A1 Test method for determining susceptibility to or state of immune system disorder or joint disorder |
| 02/13/2013 | EP2557178A1 Method for detecting pneumonia causative bacteria using nucleic acid chromatography |
| 02/13/2013 | EP2557175A2 Cambium/Xylem-preferred promoters and uses thereof |
| 02/13/2013 | EP2557174A2 Cambium/Xylem-preferred promoters and uses thereof |
| 02/13/2013 | EP2557173A2 Cambium/Xylem-preferred promoters and uses thereof |
| 02/13/2013 | EP2557172A2 Cambium/Xylem-preferred promoters and uses thereof |
| 02/13/2013 | EP2557171A2 Cambium/Xylem-preferred promoters and uses thereof |
| 02/13/2013 | EP2557170A2 Cambium/Xylem-preferred promoters and uses thereof |
| 02/13/2013 | EP2557169A2 Cambium/Xylem-preferred promoters and uses thereof |
| 02/13/2013 | EP2557168A2 Cambium/Xylem-preferred promoters and uses thereof |
| 02/13/2013 | EP2557167A2 Cambium/Xylem-preferred promoters and uses thereof |
| 02/13/2013 | EP2557166A2 Cambium/Xylem-preferred promoters and uses thereof |
| 02/13/2013 | EP2557165A2 Cambium/Xylem-preferred promoters and uses thereof |
| 02/13/2013 | EP2557164A1 Induced activation in dendritic cells |
| 02/13/2013 | EP2557163A1 Bacterially formed microcin S, a new antimicrobial peptide, effective against pathogenic microorganisms, e.g. enterohemorrhagic Escherichia coli (EHEC) |
| 02/13/2013 | EP2557161A1 Method for isolating RNA from full blood samples |
| 02/13/2013 | EP2557160A2 Mutated D-aminotransferase and method for producing optically active glutamic acid derivatives using the same |
| 02/13/2013 | EP2557159A1 Prognostic method for pulmonary adenocarcinoma, pulmonary adenocarcinoma detection kit, and pharmaceutical composition for treating pulmonary adenocarcinoma |
| 02/13/2013 | EP2557157A1 Protein capable of binding specifically to immunoglobulin, and immunoglobulin-binding affinity ligand |
| 02/13/2013 | EP2557156A1 Primer and probe for detecting chlamydia trachomatis, and method for detecting chlamydia trachomatis using same |
| 02/13/2013 | EP2557152A1 Key genes, micrornas, other non-coding rnas and combinations thereof for identifying and regulating pluripotency of cells |
| 02/13/2013 | EP2557090A2 Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders |
| 02/13/2013 | EP2557089A2 Compositions and methods for immunomodulation |
| 02/13/2013 | EP2556839A2 Pharmaceutical composition for preventing or treating heart failure and method for screening agent for preventing or treating heart failure |
| 02/13/2013 | EP2556747A2 Antibody producing non-human mammals. |
| 02/13/2013 | EP2556161A1 Methods for the treatment of autoimmune diseases |
| 02/13/2013 | EP2556160A2 Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antisense transcript to fgf21 |
| 02/13/2013 | EP2556159A1 Modulation of cetp expression |
| 02/13/2013 | EP2556158A1 Chromatographic device and method for isolating and purifying nucleic acids |
| 02/13/2013 | EP2556157A1 Method for precipitating anionic surfactant ions in the presence of nucleic acids |
| 02/13/2013 | EP2556156A1 Method for selective isolation and purification of nucleic acids |
| 02/13/2013 | EP2556155A1 Method and kit for separating viral and prokaryotic nucleic acids from eukaryotic nucleic acids |
| 02/13/2013 | EP2556154A1 Compositions and methods for the rapid detection of legionella pneumophila |
| 02/13/2013 | EP2556150A1 Viral particle released after infection of mammalian cells by human cytomegalovirus (hcmv) containing a fusion protein and use thereof |
| 02/13/2013 | EP2556149A1 Cell poration |
| 02/13/2013 | EP2556143A1 Method for isolating and purifying nucleic acids |
| 02/13/2013 | EP2556089A1 Self-assembling half-antibodies |
| 02/13/2013 | EP2556087A1 Albumin derivatives and variants |
| 02/13/2013 | EP2556086A1 Btnl9 proteins, nucleic acids, and antibodies and uses thereof |
| 02/13/2013 | EP2556084A1 Cdca5 peptides and vaccines including the same |
| 02/13/2013 | EP2555778A1 Compositions and methods for inhibiting expression of cd274/pd-l1 gene |
| 02/13/2013 | EP2555611A1 Preparation of recombinant human plasma phospholipid transfer protein (pltp) from the milk of transgenic animals |
| 02/13/2013 | EP2481799A9 Method for transforming stramenopile |
| 02/13/2013 | EP2479270A9 Gene expressing a bifidobacterium surface-presented fusion protein |
| 02/13/2013 | CN1520256B Use of follistatin to increase muscle mass |
| 02/13/2013 | CN102933721A Combinatorial sequence barcodes for high throughput screening |
| 02/13/2013 | CN102933718A Method of producing astaxanthin by fermentation |
| 02/13/2013 | CN102933715A Novel method for producing 3-hydroxypropionic acid from glycerol |
| 02/13/2013 | CN102933713A Viral-based transient-expression vector system that allows multiple applications |
| 02/13/2013 | CN102933712A Regulatory sequences for modulating transgene expression in plants |
| 02/13/2013 | CN102933711A Treatment of sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a sirtuin (SIRT) |
| 02/13/2013 | CN102933710A Method of generating gene mosaics |
| 02/13/2013 | CN102933709A A polynucleotide encoding ppat derived from jatropha and use thereof |
| 02/13/2013 | CN102933706A Viral particle released after infection of mammalian cells by human cytomegalovirus (hcmv) containing a fusion protein and use thereof |
| 02/13/2013 | CN102933600A Methods and composition for secretion of heterologous polypeptides |
| 02/13/2013 | CN102933596A Polypeptide having glucoamylase activity and polynucleotide encoding the polypeptide |
| 02/13/2013 | CN102933594A Brucella phage polynucleotides and uses thereof |
| 02/13/2013 | CN102933227A Compositions comprising boosting polypeptide and starch degrading enzyme and uses thereof |
| 02/13/2013 | CN102933074A Production of fertile xy female animals from xy es cells |
| 02/13/2013 | CN102933073A Plant peptide gamma-zein for delivery of biomolecules into plant cells |
| 02/13/2013 | CN102933072A Barley and uses thereof |
| 02/13/2013 | CN102925987A Construction method of random shRNA library |
| 02/13/2013 | CN102925590A Detection primer and method for detecting bombyx mori cytoplasmic polyhedrosis virus (BmCPV) |
| 02/13/2013 | CN102925578A Detection reagent kit and detection method of aeromonas bacteria |
| 02/13/2013 | CN102925576A Primer for detecting activity of wheat grain lipoxidase and application thereof |
| 02/13/2013 | CN102925574A Primers special for detecting coxiella burnetii |
| 02/13/2013 | CN102925572A Polymerase chain reaction (PCR) system for identifying wheat vernalization gene VRN-A1 and VRN-D1 |
| 02/13/2013 | CN102925571A Polymerase chain reaction (PCR) system for identifying wheat vernalization gene VRN-A1 and VRN-B1 |
| 02/13/2013 | CN102925570A Polymerase chain reaction (PCR) system for identifying wheat vernalization gene VRN-A1 |
| 02/13/2013 | CN102925569A MicroRNA (ribonucleic acid) marker set for detecting breast cancer and application of microRNA marker set in kit |
| 02/13/2013 | CN102925568A Primer and probe for detecting acidovorax citrulli and detection method for acidovorax citrulli |
| 02/13/2013 | CN102925565A Method for identifying nucleotide point mutation of phytophthora sojae beta-microtubulin gene and use thereof for diagnosing zoxamide resistance |
| 02/13/2013 | CN102925564A Use and expression vector of gene C2orf40 in preparation of medicines for preventing, diagnosing or treating tumor of breast and diagnosis medicine thereof |
| 02/13/2013 | CN102925555A Sequencing primer pair for qualitatively detecting human BRAF V600E gene mutation and kit thereof |